BIOCRYST PHARMACEUTICALS, INC.: cash_and_equivalents
| Value | {"amount": 154972000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2026-06-30) |
| Status | current |
| Entity | BIOCRYST PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:48:50.529413+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/594b5e99-3b7a-4508-9977-3a7af81c78b1
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-26-053300Retrieved: 2026-08-19T08:48:50.529413+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000882796/cash-and-equivalents/2026-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/594b5e99-3b7a-4508-9977-3a7af81c78b1
History
- no predecessors — first report